The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...

Drugs and weight loss often go hand in hand, but the journey can feel overwhelming—especially when your wallet takes a hit.

Yep, you can actually be thrown in jail for buying certain weight loss drugs on Facebook (or any other social media platform, ...

Here's what to know about weight loss drugs such as Wegovy and Zepbound. CR helps you decide whether semaglutide or ...

As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic ...

Tirzepatide is the active ingredient in the U.S. firm's diabetes drug Mounjaro, and weight-loss drug Zepbound ... competition ...